Form 4: ADMA Director Exercises Options, Gifts Shares to Trust

ADMA Biologics Director Lawrence P. Guiheen exercised stock options and subsequently gifted a portion of his common stock to an irrevocable trust.

Summary

• Lawrence P. Guiheen, a Director of ADMA Biologics, Inc., exercised options to acquire 30,000 shares of common stock at an exercise price of $3.66 per share on March 13, 2026.
• Following the option exercise, Mr. Guiheen's direct beneficial ownership increased to 135,520 shares of common stock.
• On March 17, 2026, Mr. Guiheen gifted 30,000 shares of ADMA common stock to the Lawrence P Guiheen Irrevocable Trust DTD 9/20/19.
• After these transactions, Mr. Guiheen's direct beneficial ownership stands at 105,520 shares, while the 2019 Guiheen Irrevocable Trust holds 30,000 shares indirectly.
• He also indirectly holds 50,990 shares in the Lawrence P Guiheen Irrevocable Trust 1 and retains 23,837 stock options.
• The option exercise was partly due to its near-term expiration date.
• Direct ownership includes 10,690 Restricted Stock Units (RSUs) granted on February 9, 2026, which will fully vest on February 9, 2027, subject to continued service.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. The option exercise indicates a director's decision to convert potential value into actual shares, often a sign of confidence, even if partly driven by expiration. The subsequent gift is primarily an estate planning move.

Positives

• The exercise of stock options by a director indicates confidence in the company's future prospects, as they are converting potential value into actual shares.
• The director's continued holding of a significant number of shares (105,520 directly and 80,990 indirectly through trusts) and remaining options (23,837) demonstrates ongoing alignment with shareholder interests.

Negatives

• The gift of 30,000 shares to a trust, while a common estate planning strategy, reduces the director's direct holdings, though control is retained.

Future Outlook

NA

Management Comments

• The Reporting Person is exercising this option due, in part, to its near-term expiration date.
• The Reporting Person disclaims beneficial ownership of the securities held by the 2019 Guiheen Irrevocable Trust, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Industry Context

StockSavvy.ai notes that insider transactions, such as option exercises and share gifts, are common occurrences in the biotechnology and pharmaceutical sectors. While the exercise of options can signal insider confidence, the subsequent gifting to a trust is often an estate planning move rather than a direct market signal about the company's immediate prospects. These types of filings are standard for directors and executives managing their equity compensation and personal holdings.

Related Party Transactions

• Gift of 30,000 shares to the Lawrence P Guiheen Irrevocable Trust DTD 9/20/19, where Mr. Guiheen retains control.

Stakeholder Impact

• Shareholders: The director's continued significant ownership, both direct and indirect, aligns his interests with those of other shareholders. The option exercise could be seen as a positive signal of confidence.

Next Steps

• The 10,690 RSUs granted on February 9, 2026, will fully vest on February 9, 2027, subject to the Reporting Person's continued service.
• The remaining 23,837 stock options will expire on June 6, 2027.

Key Dates

Recommendation

The filing details routine insider transactions, specifically an option exercise and a subsequent gift of shares to a trust. While the option exercise can be interpreted as a sign of confidence, the overall activity is typical for executive compensation and estate planning. It does not provide new fundamental information about ADMA Biologics' operational performance or strategic direction that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on existing company fundamentals rather than these specific insider transactions.

Keywords

ADMA Biologics, ADMA, Insider Trading, Form 4, Stock Option Exercise, Share Gift, Director Ownership, Beneficial Ownership, Equity Transactions, Lawrence P. Guiheen